BML, Inc.
Research BML, Inc. (4694.T) on Bullrun: market cap JPY 143.75B, P/E 18.4, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4694.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyJPY
- Market capJPY 143.75B
- P/E18.4
- Dividend yield3.3%
- Financial periodFY2026
- RevenueJPY 150.26B
- Revenue growth4.9%
- Net incomeJPY 7.75B
- Free cash flowJPY 10.59B
- Gross margin32.4%
Valuation Snapshot
latest market cap is JPY 143.75B; P/E is 18.4; dividend yield is 3.3%.
Peer valuation comparison
Latest P/E is 18.39x versus a Healthcare sector median of 21.69x (15.2% below).
Latest dividend yield is 3.32% versus a Healthcare sector median of 2.41% (37.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 150.26B | JPY 7.75B | JPY 10.59B | 32.4% | 203.45 | JPY 68.03B | JPY 4.82B | JPY 127.67B |
| FY2025 | JPY 143.19B | JPY 6.26B | -JPY 849.00M | 32.0% | 160.55 | JPY 67.56B | JPY 5.29B | JPY 129.40B |
| FY2024 | JPY 137.96B | JPY 6.03B | -JPY 6.48B | 33.1% | 154.74 | JPY 74.11B | JPY 5.27B | JPY 125.86B |
| FY2023 | JPY 159.46B | JPY 15.58B | JPY 5.28B | 38.5% | 395.62 | JPY 86.52B | JPY 4.15B | JPY 122.49B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 143.75B | 18.4 | 3.3% | 125 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 125 JPY, yield 3.3%.
| Year | Dividends/share |
|---|---|
| FY2026 | 127.5 JPY |
| FY2025 | 130 JPY |
| FY2024 | 90 JPY |
| FY2023 | 100 JPY |
| FY2022 | 125 JPY |
About BML, Inc.
BML, Inc. provides contract clinical testing and related services in Japan. The company offers routine laboratory testing, such as biochemical and hematologic examination; special laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BML, Inc.'s market cap?
BML, Inc.'s market capitalization is JPY 143.75B.
What is BML, Inc.'s P/E ratio?
BML, Inc.'s price-to-earnings (P/E) ratio is 18.4.
Does BML, Inc. pay a dividend?
BML, Inc. has a dividend yield of 3.3%.
What does BML, Inc. do?
BML, Inc. provides contract clinical testing and related services in Japan. The company offers routine laboratory testing, such as biochemical and hematologic examination; special laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing.